Syantra
Calgary, CA · 2 known investors
Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.
Founders & leadership
DT
Dr. Tina RinkerCo-founder
TR
Tina RinkerCo-founder
KF
Ken FuhCo-founder
RM
Randy MooreCo-founder
BS
Bob ShepherdCo-founder